Rein Therapeutics Inc. (RNTX) Earnings
Rein Therapeutics Inc. is expected to report next earnings on November 13, 2026 (in NaN days), with a consensus EPS estimate of $-0.10. RNTX has beaten EPS estimates in 4 of its last 12 reported quarters (average surprise -73.4% over the last four).
Next earnings
Nov 13, 2026in NaN days
EPS est $-0.10 · Revenue est —
Track record
Beat EPS in 4 of 12 quarters
Avg surprise -73.4% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| Aug 14, 2026 | $-0.17 | $-0.10 | +41.2% | — | — |
| May 15, 2026 | $-0.49 | $-0.19 | +61.2% | — | — |
| Mar 26, 2026 | $-0.24 | $-1.22 | -408.3% | — | — |
| Nov 14, 2025 | $-0.24 | $-0.21 | +12.5% | — | — |
| Aug 14, 2025 | $-0.22 | $-0.28 | -27.3% | — | — |
| Apr 7, 2025 | $-0.14 | $-0.26 | -85.7% | — | — |
| Dec 31, 2024 | $-0.46 | $-1.89 | -310.7% | — | — |
| Aug 14, 2024 | $-0.25 | $-0.45 | -80.0% | — | — |
| Mar 31, 2024 | $-0.14 | $-0.86 | -512.0% | — | — |
| Dec 31, 2023 | $-0.16 | $-1.54 | -840.0% | — | — |
| Sep 30, 2023 | $-0.20 | $-0.40 | -101.2% | — | — |
| Jun 30, 2023 | $-0.40 | $-0.39 | +1.6% | — | — |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.